BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7672654)

  • 1. [Preoperative management of uterine leiomyomatosis using pituitary gonadotropin-releasing hormone analogues].
    Bustos López HH; Miranda Rodríguez JA; Kably Ambe A; Serviere Zaragoza C; Espinoza de los Monteros A; Alvarado Durán A
    Ginecol Obstet Mex; 1995 Aug; 63():356-64. PubMed ID: 7672654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term and long-term results of resectoscopic myomectomy with and without pretreatment with GnRH analogs in premenopausal women.
    Campo S; Campo V; Gambadauro P
    Acta Obstet Gynecol Scand; 2005 Aug; 84(8):756-60. PubMed ID: 16026401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal therapy before surgical treatment for uterine leiomyomas.
    Moghissi KS
    Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of gonadotropin-releasing hormone agonists before myomectomy.
    Friedman AJ
    Clin Obstet Gynecol; 1993 Sep; 36(3):650-9. PubMed ID: 8403611
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix.
    Gonzalez-Barcena D; Alvarez RB; Ochoa EP; Cornejo IC; Comaru-Schally AM; Schally AV; Engel J; Reissmann T; Riethmüller-Winzen H
    Hum Reprod; 1997 Sep; 12(9):2028-35. PubMed ID: 9363724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: assessment by magnetic resonance imaging.
    Andreyko JL; Blumenfeld Z; Marshall LA; Monroe SE; Hricak H; Jaffe RB
    Am J Obstet Gynecol; 1988 Apr; 158(4):903-10. PubMed ID: 2966587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy: efficacy and ultrasonographic predictors.
    Zullo F; Pellicano M; De Stefano R; Zupi E; Mastrantonio P
    Am J Obstet Gynecol; 1998 Jan; 178(1 Pt 1):108-12. PubMed ID: 9465812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective randomised trial comparing gonadotrophin-releasing hormone analogues with triple tourniquets at open myomectomy.
    Al-Shabibi N; Chapman L; Madari S; Papadimitriou A; Papalampros P; Magos A
    BJOG; 2009 Apr; 116(5):681-7. PubMed ID: 19191779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of uterine fibroids with GnRH-analogues prior to hysterectomy.
    Stjernquist M
    Acta Obstet Gynecol Scand Suppl; 1997; 164():94-7. PubMed ID: 9225649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of uterine fibroids: current findings with gonadotropin-releasing hormone agonists.
    Adamson GD
    Am J Obstet Gynecol; 1992 Feb; 166(2):746-51. PubMed ID: 1531577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale for the short-term use of luteinising hormone-releasing hormone analogues in the treatment of uterine myomata.
    Stovall TG
    Horm Res; 1989; 32 Suppl 1():134-6. PubMed ID: 2693324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-surgical treatment of uterine myomas with LH-RH agonists.
    D'Addato F; Repinto A; Andreoli C
    Clin Exp Obstet Gynecol; 1992; 19(1):45-50. PubMed ID: 1535032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preoperative treatment with GnRH analogs in hysterectomy].
    Serrao L; Brizzi C; Primiero FM
    Clin Ter; 1994 Nov; 145(11):403-6. PubMed ID: 7889725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Medical treatment of uterine leiomyomatosis with an agonist of pituitary gonadotropins (GnRH). Presentation of a case].
    Bustos HH; López Garcia R; Sánchez V; Contreras J; Ayala Ruiz A
    Ginecol Obstet Mex; 1990 Sep; 58():260-4. PubMed ID: 2125961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [LH-RH analogues in the preparation of hysteroscopic resection of uterine fibromyoma].
    Pace S; Labi FL; Lotti G; Mastrone M; Grassi A
    Minerva Ginecol; 1992 May; 44(5):245-50. PubMed ID: 1608522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
    Schneider D; Golan A; Bukovsky I; Pansky M; Caspi E
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):540-1. PubMed ID: 1831252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of uterine leiomyomas and hirsutism with nafarelin.
    Monroe SE; Andreyko J
    J Reprod Med; 1989 Dec; 34(12 Suppl):1029-33. PubMed ID: 2533618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of pre-operative treatment with GnRH analogues in women with submucous fibroids: a double-blind, placebo-controlled randomized trial.
    Mavrelos D; Ben-Nagi J; Davies A; Lee C; Salim R; Jurkovic D
    Hum Reprod; 2010 Sep; 25(9):2264-9. PubMed ID: 20663795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
    Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
    Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
    Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.